Lung cancer bone spread study seeks 100 volunteers
NCT ID NCT03958565
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how bone tumors respond to treatment in people with non-small cell lung cancer. Researchers will measure bone health markers in urine and blood before and after treatment. The goal is to see if targeted pills (TKIs) or standard treatments like chemotherapy or immunotherapy help reduce bone damage. Participants must be 18-100 years old with confirmed lung cancer that has spread to bones.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lone Tree Medical Center
RECRUITINGLone Tree, Colorado, 80124, United States
-
University of Colorado Hospital
RECRUITINGAurora, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immunotherapy be safely used in early lung cancer? a Real-World study investigates
- Can an oral chemo pill boost immunotherapy's power against lung cancer?
- Can an immunotherapy cocktail shrink inoperable lung tumors?
- Immunotherapy boosts radiation against early lung cancer
- Lab-Grown lung tumors could reveal why some drugs work and others fail
- AI-Powered navigation aims to pinpoint tiny lung nodules during surgery